 L- M2-type pyruvate kinase liver 1-day old rats demonstrated significant activation inhibition treatment cyclic AMP, glucagon insulin. Neither change isozymic composition. means incorporation [3H]leucine followed immunoprecipitation, rates synthesis L- M2-type pyruvate kinase considerably affected three modulators. Insulin glucagon direct immediate change synthesis liver pyruvate kinase fluctuation insulin/glucagon ratio probable signal regulating isozymic expression neonatal period.